How Your Body Actually Runs the Fat-Loss Equation

By Ryan Jourabchian, Wellness Optimization Director, Butler Wellness Group

For years, weight loss has often been reduced to a simple instruction: eat less and move more.

Energy balance matters, but weight loss is not just a simple calories-in, calories-out equation. Appetite, fullness, blood sugar, insulin, digestion, and energy use are influenced by several interconnected hormone systems.

Three hormones that have become especially important in the conversation around metabolic health are GLP-1, GIP, and glucagon. Understanding what they do can make the growing number of weight-loss medications and terms online easier to understand.

This information is general education and is not a substitute for individualized medical advice.

First, Clear Up the Labels

People sometimes talk about “GLP-1,” “GLP-2,” and “GLP-3” as though they are first-, second-, and third-generation versions of the same type of weight-loss medication.

That is not how the terminology works.

GLP-2 is a different hormone with its own role in the body, and “GLP-3” is not the scientific name for a weight-loss medication class.

What people are often trying to describe is how many hormone receptors a medication targets.

Some medications target the GLP-1 receptor. Others act on both GLP-1 and GIP receptors. Investigational medications are also being studied that target GLP-1, GIP, and glucagon receptors together.

These are different hormonal pathways, not simply stronger versions of the same thing.

GLP-1: Appetite, Fullness, and Blood Sugar

GLP-1, or glucagon-like peptide-1, is a hormone released by the gut after eating.

It helps coordinate several responses to a meal. GLP-1 can increase insulin release when blood sugar is elevated, reduce glucagon secretion, influence appetite and fullness, and slow gastric emptying.

Together, those effects help explain why the GLP-1 pathway has become important in the treatment of type 2 diabetes and obesity.

The body’s natural GLP-1 signal is short-lived, while GLP-1 receptor agonist medications are designed to activate that pathway for longer. Some effects, such as slowing gastric emptying, may also become less pronounced with continued use.

GIP: Another Part of the Incretin System

GIP, or glucose-dependent insulinotropic polypeptide, is another gut hormone released after eating.

Like GLP-1, it is involved in the incretin effect, where the digestive system helps signal the pancreas that nutrients are arriving and increases the insulin response to food.

GIP and GLP-1 do not behave identically, and researchers are still working to fully understand GIP’s role in appetite, metabolism, and weight regulation.

Medications acting on both GLP-1 and GIP receptors can affect blood sugar regulation and body weight differently than targeting GLP-1 alone.

Glucagon: More Complicated Than “Raises Blood Sugar”

Glucagon is commonly known as the hormone that helps raise blood sugar, which can make its role in newer metabolic medications seem confusing.

But glucagon does more than one thing.

Researchers are studying how activating the glucagon receptor alongside GLP-1 and GIP receptors may affect energy expenditure, liver metabolism, and body weight while the other pathways help regulate appetite and blood sugar.

Triple-receptor medications have now reached late-stage human trials, but questions remain about exactly how much each receptor contributes to the overall effect.

The important distinction is that adding another receptor adds another biological pathway. It is not simply a larger dose of the same mechanism.

The Scale Is Only One Part of Metabolic Health

Weight is an obvious measurement because it is easy to see, but it does not tell the entire story.

Depending on the individual, healthcare providers may also consider:

• Blood sugar regulation
• Insulin sensitivity
• Triglycerides and other blood lipids
• Liver health and liver fat
• Blood pressure
• Body composition

Changes in these areas do not always move at exactly the same pace as the number on the scale.

Weight is one outcome. Metabolic health is a bigger picture.

Muscle Matters During Weight Loss

When someone loses a significant amount of weight, some lean mass can be lost along with body fat.

That is why focusing only on the scale can miss an important part of the conversation.

Protein intake and resistance training are two important tools for supporting muscle during weight loss. Resistance training gives the body a reason to maintain muscle, while adequate nutrition provides the resources needed to support it.

Body-composition measurements also need context. “Lean mass” includes more than skeletal muscle, so a change in lean mass does not automatically mean the same amount of functional muscle was lost.

The goal is not simply to become lighter. Maintaining strength and physical function matters too.

What We Know and What Is Still Developing

The science around these hormone pathways is moving quickly.

More established: GLP-1 medications have been extensively studied for their effects on appetite, fullness, blood sugar regulation, and weight. GLP-1/GIP medications also have substantial clinical evidence in type 2 diabetes and obesity.

Still developing: Researchers continue to study the exact role of GIP and how adding glucagon receptor activity affects energy expenditure, body composition, liver metabolism, and other outcomes.

Emerging treatments should not automatically be described as simply “stronger” or “better.”

The Lifestyle Foundation Still Matters

Understanding these hormone pathways does not make the basics irrelevant.

Nutrition, resistance training, sleep, stress management, recovery, and daily structure remain important whether or not medication is part of someone’s care.

At Butler Wellness Group, coaching focuses on those lifestyle factors.

Anything involving medication selection, prescribing, dosing, lab interpretation, medical risks, or determining whether a treatment is appropriate belongs with a licensed prescribing provider. When appropriate, medical care through Butler Wellness Group is handled by independent licensed providers in the Asher Health network.

Coaches do not prescribe medications or make clinical decisions.

Where This Leaves You

There are three useful ideas to take away:

1. Weight regulation involves more than willpower. Appetite, blood sugar, hormones, activity, nutrition, sleep, stress, and other factors interact.
2. Medical tools do not replace the lifestyle foundation. Supporting muscle, eating well, sleeping consistently, managing stress, and staying active still matter.
3. Whether a medication belongs in your plan is an individual medical decision. An article can help you understand the biology, but it cannot determine what treatment is appropriate for you.

If you want help looking at the lifestyle side, a Wellness Optimization Consultation with Butler Wellness Group can look at how your nutrition, sleep, stress, training, recovery, and daily routine fit together. Anything clinical stays within the provider lane.

Understanding the biology can help you ask better questions. The individual decision still belongs between you and your healthcare provider.

This content is for educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Butler Wellness Group does not prescribe medication. Prescribing, lab interpretation, and individualized medical decisions should be handled by an appropriate licensed healthcare provider.